NMN Dosage Guide: How Much Should You Take Per Day?
Human clinical trials have tested NMN at doses from 100 mg to 1250 mg daily. Blood NAD+ increases significantly from 300 mg upward, with the strongest effects at 600 mg. A sensible starting point is 250-300 mg daily, moving to 500-600 mg once established. Take it in the morning. No adverse effects have been reported in trials at any dose up to 1250 mg. This guide covers what the evidence says about dosing, timing, and how to adjust for your goals.
What Human Clinical Trials Actually Tested
Before giving a dosage recommendation, it is worth being clear about where the numbers come from. There is no official government-approved recommended daily allowance for NMN. The doses used in clinical trials are the most reliable reference points we have. Here is the dose landscape from human studies:
The first human NMN pharmacokinetics study, conducted at Keio University School of Medicine in Japan and published in 2020, administered single oral doses of 100 mg, 250 mg, and 500 mg to healthy men. All doses were safe and well-tolerated, with no significant adverse clinical effects observed, and NMN metabolites in plasma increased in a dose-dependent manner across the 5-hour measurement window.
A 2020 study by Irie, Inagaki, Fujita et al. (Keio University School of Medicine, Tokyo), published in Endocrine Journal, was the first human clinical investigation of NMN pharmacokinetics and safety at doses of 100 mg, 250 mg, and 500 mg. The researchers found that single oral NMN doses were safe and effectively metabolised, with no clinically significant changes in vital signs, blood pressure, heart rate, or ophthalmic markers. Nicotinamide metabolite levels in plasma increased dose-dependently following administration, confirming that NMN is absorbed and metabolically active in humans at these doses.
Source: Irie J, Inagaki E, Fujita M et al., Endocr J, 2020, PMID:31685720Subsequent trials expanded the dose range. A large dose-dependent randomised controlled trial in 80 middle-aged adults tested 300 mg, 600 mg, and 900 mg daily for 60 days, finding significant blood NAD+ increases across all groups. A runner trial tested 300 mg, 600 mg, and 1200 mg combined with exercise. A metabolic trial used 250 mg in postmenopausal women with prediabetes. A high-dose safety trial confirmed tolerability at 1250 mg daily for four weeks. Across all of these, no serious adverse effects were reported.
The Three Practical Dose Tiers
Starting Dose: 250-300 mg per Day
For most people beginning NMN supplementation, 250-300 mg daily is a reasonable entry point. It was the dose used in the first human pharmacokinetics study, it falls within the range of all subsequent trials, and it is the dose that demonstrated significant metabolic effects in the Washington University prediabetes trial. It is also the dose most commonly cited by healthcare practitioners for initial use.
At this dose, blood NAD+ elevation is measurable and consistent. For someone who has not taken NMN before, this allows assessment of individual response before committing to higher amounts. Many people maintain this dose long-term if their primary goal is foundational cellular maintenance rather than addressing a specific deficit.
Standard Dose: 500-600 mg per Day
Based on the dose-response data across multiple trials, 600 mg daily is the level at which the strongest and most consistent effects on blood NAD+ and physical performance have been observed. The 60-day randomised trial in middle-aged adults found the greatest increases in blood NAD+ concentrations at 600 mg, with diminishing additional returns at 900 mg. The runner trial found significant aerobic capacity improvements beginning at 600 mg but not at 300 mg.
For individuals supplementing NMN specifically to address energy, physical performance, or the NAD+ decline associated with aging (which becomes more pronounced from the late 30s onward), 500-600 mg daily represents the sweet spot: well within the established safety range and at the level where the evidence for benefit is strongest.
Practical note for powder users: At 600 mg per day, a 15g jar of Solensis NMN Powder provides approximately 25 days of supplementation. At 300 mg, it provides approximately 50 days. The powder dissolves readily in water and can be taken as a morning drink.
Higher Doses: 900-1250 mg per Day
Human trials have established safety at up to 1250 mg daily for four weeks, and at 900 mg daily for 60 days. These higher doses are well-tolerated but do not appear to produce proportionally greater NAD+ elevation compared to 600 mg. The dose-response curve flattens at higher amounts, meaning additional benefit does not scale linearly with additional dose.
Higher doses are sometimes discussed in the context of individuals with significantly impaired NAD+ metabolism, older adults, or those with specific health conditions that increase NAD+ consumption (such as chronic inflammation or significant oxidative stress). For most people without these specific circumstances, doses above 600 mg daily represent additional cost without proportional additional benefit based on current evidence.
| Daily Dose | Evidence Base | Best For |
|---|---|---|
| 100-250 mg | Safety confirmed; first human pharmacokinetics study (Irie 2020) | Starting out; conservative approach; younger adults |
| 300 mg | Significant blood NAD+ increase in RCT; physical performance improved at this dose in 60-day trial | Maintenance dose; cost-conscious supplementation |
| 500-600 mg | Strongest blood NAD+ effects across dose-dependent trials; aerobic capacity gains begin at this level | Standard effective dose; most consistent benefit range |
| 900 mg | Safe and effective in 60-day RCT; NAD+ effects similar to 600 mg | Older adults; those with significant NAD+ deficit |
| 1200-1250 mg | Safe in 4-week and 6-week human trials; no additional NAD+ advantage over lower doses | Not recommended for general use; limited additional benefit vs cost |
Start With a Dose You Can Trust
Solensis NMN Powder: greater than or equal to 98% purity. Allows precise dose adjustment. GMP-certified. Third-party tested. Made in the USA.
Shop Solensis NMN PowderWhen to Take NMN: Morning vs Night
Morning is the most evidence-supported time to take NMN. The rationale has two pillars.
First, NAD+ is central to cellular energy metabolism and alertness-related biochemistry. Taking NMN in the morning aligns supplementation with the period of highest energy demand, when cells can most actively use the NAD+ being generated. Second, SIRT1, one of the primary Sirtuin proteins activated by NAD+, plays a direct role in circadian rhythm regulation. NAD+ biosynthesis via NAMPT is itself circadian-regulated, with peaks in the morning. Supplementing NMN in the morning reinforces this natural cycle rather than working against it.
Most human clinical trials administered NMN in the morning, often before breakfast or with a morning meal. This makes the morning protocol not just biologically sensible but also the approach that aligns with the evidence base.
Evening or night dosing is not contraindicated by the evidence, and some people split their daily dose between morning and evening for convenience. There is no clinical data specifically comparing morning-only versus split-dose protocols.
Taking NMN With or Without Food
NMN is water-soluble and can be taken with or without food. In powder form, it dissolves readily in water and can be consumed before or with a meal. There is no evidence that fasting is required for absorption. Taking it with a small meal may improve tolerability for anyone who experiences mild gastric sensitivity on an empty stomach, though this is uncommon based on the adverse event profiles in clinical trials.
One practical consideration: NMN is absorbed relatively quickly (measurable blood levels within 30 minutes), so the timing relative to food does not appear to significantly alter absorption kinetics in the way it might for fat-soluble compounds. Taking it dissolved in water first thing in the morning is a simple and consistent protocol.
Does the Right Dose Change With Age or Goal?
There is no established age-specific NMN dosage protocol based on current clinical data. The biological rationale for considering a higher dose with age is straightforward: NAD+ declines more with age, so the deficit being addressed is larger in a 60-year-old than in a 35-year-old. Human trials have not yet formally compared outcomes across age groups using different doses, so this remains practical reasoning rather than clinical evidence.
By goal:
Foundational cellular maintenance (30s-40s): 250-300 mg daily is a defensible starting point for someone proactively supplementing during a period when NAD+ decline is beginning but not yet severe. This is also the dose most consistent with conservative longevity protocols.
Active NAD+ restoration (50s onward): 500-600 mg daily addresses the larger deficit associated with more substantial NAD+ decline. The physical performance and metabolic data at this dose range are also more directly relevant to the health priorities of this age group.
Performance and active lifestyle: 600 mg combined with regular exercise is the dose at which aerobic capacity improvements were observed in the runner trial. For active individuals, aligning NMN use with a consistent exercise practice appears to amplify the benefit.
NMN Powder vs Capsule: Does Format Affect Dosing?
The active molecule is the same regardless of format. NMN powder dissolved in water and NMN in a capsule deliver the same compound. Powder offers the advantage of precise dose adjustment: you can easily measure 250 mg, 400 mg, or 600 mg without being locked into a fixed capsule size. This is particularly useful when starting at a lower dose and titrating upward.
Capsules offer convenience and portability. The disadvantage is dose inflexibility and the additional excipients (fillers, binders) that come with encapsulation, which vary in quality across manufacturers.
Absorption rate between powder and capsule is not meaningfully different for NMN. The primary variable is the quality and purity of the NMN itself, not the delivery format.
Start at 250-300 mg daily in the morning, dissolved in water. Move to 500-600 mg if your goal is active NAD+ restoration, particularly from the late 30s onward or if you are physically active. No adverse effects have been documented in human trials at any dose up to 1250 mg. Quality (purity and third-party testing) matters more than precise dose within the established effective range. Always consult a healthcare provider for personalised guidance.
Frequently Asked Questions
How much NMN should I take a day?
Human clinical trials have tested NMN at doses from 100 mg to 1250 mg daily. Blood NAD+ increases significantly from 300 mg upward. A common starting dose is 250-300 mg daily, with many people moving to 500-600 mg once established. Clinical trials found the strongest effects on blood NAD+ and physical performance at 600 mg daily. No adverse effects have been reported at doses up to 1250 mg in controlled trials. Consult a healthcare provider for personalised guidance.
What is the recommended daily dosage for NMN?
There is no official government-established recommended daily allowance for NMN. Based on human clinical trial data, doses of 300 mg to 900 mg daily have demonstrated significant increases in blood NAD+ with no adverse effects. The most commonly referenced effective range is 500-600 mg per day, based on the dose-response relationship observed across multiple trials.
When should I take NMN, morning or night?
Morning is the most evidence-supported time for NMN supplementation. NAD+ is involved in cellular energy metabolism and plays a role in circadian rhythm regulation via SIRT1. Aligning NMN intake with active hours is consistent with the biology. Most human clinical trials administered NMN in the morning, often before breakfast or with a morning meal. There is no evidence that evening dosing is harmful, but morning dosing is the standard protocol.
Should I take NMN with food?
NMN can be taken with or without food. For Solensis NMN Powder, dissolving it in water and taking it in the morning, with or shortly before a light meal, is a practical approach that aligns with how most clinical trials administered the supplement. Taking it with a small amount of fat may support absorption, though this has not been definitively tested for NMN specifically.
Does the NMN dose change with age?
There is no formally established age-based NMN dosage protocol. The general rationale for considering higher doses with age is that NAD+ declines more significantly over time, so the deficit being addressed is larger. Many practitioners working with longevity protocols suggest starting at the lower end of the effective range regardless of age and adjusting based on individual response.
How much NMN powder should I take per day?
For Solensis NMN Powder, a standard dose is typically 0.25g (250mg) to 0.5g (500mg) per serving, dissolved in water. The powder form allows for precise dose adjustment. At 600mg per day, a 15g jar provides approximately 25 days of supplementation. Store in a cool, dry place away from light and moisture to preserve potency.
Can you take too much NMN?
No adverse effects have been reported in controlled human trials at doses up to 1250 mg daily for up to four weeks. Safety across trials up to 900 mg daily is well-documented. Very high doses are not more effective for NAD+ elevation than moderate ones, and the additional cost without proportional benefit makes them unnecessary for most people. As with any supplement, staying within the range tested in humans and consulting a healthcare provider is the prudent approach.
Precise Dosing Starts With Pure NMN
Solensis NMN Powder: greater than or equal to 98% purity. GMP-certified. Third-party tested by Adamson Analytical Laboratories. Made in the USA. 30-day money-back guarantee.
Shop Solensis NMN Powder